Catalyst Pharmaceutical (CPRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 05/04/26
Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026GlobeNewsWire • 04/28/26
Catalyst (CPRX) is on the Move, Here's Why the Trend Could be SustainableZacks Investment Research • 04/27/26
Strength Seen in Catalyst (CPRX): Can Its 6.7% Jump Turn into More Strength?Zacks Investment Research • 04/24/26
Does Catalyst (CPRX) Have the Potential to Rally 28.87% as Wall Street Analysts Expect?Zacks Investment Research • 04/15/26
Wall Street Analysts Predict a 45.3% Upside in Catalyst (CPRX): Here's What You Should KnowZacks Investment Research • 03/30/26
Catalyst (CPRX) Down 2.5% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/27/26
Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock?Zacks Investment Research • 03/20/26
Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/10/26
How Much Upside is Left in Catalyst (CPRX)? Wall Street Analysts Think 43.34%Zacks Investment Research • 03/06/26
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific ConferenceGlobeNewsWire • 03/06/26
All You Need to Know About Catalyst (CPRX) Rating Upgrade to Strong BuyZacks Investment Research • 03/04/26
Are Investors Undervaluing Catalyst Pharmaceuticals (CPRX) Right Now?Zacks Investment Research • 03/04/26
Catalyst Pharmaceuticals Q4 Earnings Beat, Firdapse Revenues Rise Y/YZacks Investment Research • 02/26/26